Gelnique and Joint swelling - a phase IV clinical study of FDA data

Summary:

Joint swelling is reported as a side effect among people who take Gelnique (oxybutynin chloride), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Myrbetriq, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Joint swelling when taking Gelnique. It is created by eHealthMe based on reports of 350 people who have side effects when taking Gelnique from the FDA, and is updated regularly.

What is Gelnique?

Gelnique has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 370 Gelnique users. Check the latest studies of Gelnique.

What is Joint swelling?

Joint swelling is found to be associated with 2,123 drugs and 2,934 conditions by eHealthMe. Check the latest studies of Joint swelling.

On Apr, 21, 2026

350 people reported to have side effects when taking Gelnique.
Among them, 11 people (3.14%) have Joint swelling.

Among these 11 people:

How long have people been on Gelnique when they have Joint swelling? *

What is the gender of people who have Joint swelling when taking Gelnique? *

female: 100 %
male: 0.0 %

What is the age of people who have Joint swelling when taking Gelnique? *

What are other drugs people take besides Gelnique? *

What are other side effects people have besides Joint swelling? *

Joint Pain: 8 people, 72.73%
High Blood Cholesterol: 7 people, 63.64%
Open Fracture: 7 people, 63.64%
Synovitis (inflammation of the synovial membrane): 7 people, 63.64%
Joint Instability (a condition in which the joints aren't sufficiently supported): 7 people, 63.64%
Diabetes: 7 people, 63.64%
Musculoskeletal Disorder (disease of the body's muscles, joints, tendons, ligaments and nerves): 7 people, 63.64%
Fall: 7 people, 63.64%
Arthropathy: 6 people, 54.55%
Fatigue (feeling of tiredness): 6 people, 54.55%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 72.73%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 7 people, 63.64%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 18.18%
Urinary Tract Infection: 1 person, 9.09%
Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
Insomnia (sleeplessness): 1 person, 9.09%
Incontinence (lack of moderation or self-control): 1 person, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 9.09%
High Blood Cholesterol: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Gelnique and have Joint swelling?

- Check whether Joint swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gelnique:

Gelnique (370 reports)

Joint swelling treatments and more:

Joint swelling (143,797 reports)

Browse all side effects of Gelnique:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint swelling:

Joint swelling (2,123 drugs)

Browse all the conditions that are associated with Joint swelling:

Joint swelling (2,934 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin chloride (the active ingredients of Gelnique) and Gelnique (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.